| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 10/17/2001 | EP1143943A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant |
| 10/17/2001 | EP1143932A1 Transnasal transport/immunisation with highly adaptable carriers |
| 10/17/2001 | EP1143925A1 Topical composition comprising n-acetylaldosamines or n-acetylamino acids |
| 10/17/2001 | EP1143806A2 Method for increasing pet activity |
| 10/17/2001 | EP0999841B1 Pharmaceutical compositions containing eletriptan hemisulphate and caffeine |
| 10/17/2001 | EP0983265A4 Endothelin receptor antagonists |
| 10/17/2001 | EP0942911B1 Benzopyranopyrrole and benzopyranopyridine alpha-1 adrenergic compounds |
| 10/17/2001 | EP0833818B1 3-acylindoles as cb2 receptor agonists |
| 10/17/2001 | EP0808103A4 Protein hydroxylation inhibitors for fibroproliferative disorders |
| 10/17/2001 | EP0776201B1 Treating anxiety |
| 10/17/2001 | EP0652871B1 Benzodiazepine derivatives |
| 10/17/2001 | EP0640065B1 Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
| 10/17/2001 | CN1318069A Factor VIIa inhibitors |
| 10/17/2001 | CN1318067A Compounds, compsns. and methods for stimulating neuronal growth and elongation |
| 10/17/2001 | CN1318059A Isoquinolines as urokinase inhibitors |
| 10/17/2001 | CN1318058A 4-carboxyamino-2-substituted-1,2,3,4-tetrahydroquinolines as CRTP inhibitors |
| 10/17/2001 | CN1318056A Pyridinum derivatives for management of aging-related and diabetic vascular complications, process for their prepn. and therepeutic uses thereof |
| 10/17/2001 | CN1317970A Method for treating atherosclerosis empolying ap2 inhibitor and combination |
| 10/17/2001 | CN1317965A Compounds having IgE affecting properties |
| 10/17/2001 | CN1317964A Composition |
| 10/17/2001 | CN1317963A Composition |
| 10/17/2001 | CN1317484A Fullerene derivative of E-isomer |
| 10/17/2001 | CN1317325A Medical tea for treating hircus and its preparing process |
| 10/17/2001 | CN1317311A Application of full-trans-tretinoin in preparing medicines to cure myocardial hypertrophy and vessel wall hyperplasia |
| 10/17/2001 | CN1317309A Instant oral medincinal preparation |
| 10/17/2001 | CN1073154C Superoxide dismutase-4 |
| 10/17/2001 | CN1073104C N-(4-acetyl-1-piperazinyl)-4-fluorobenzamide hydrate |
| 10/17/2001 | CN1073103C Compounds and compsns. for treating diseases associated with tryptase activity |
| 10/17/2001 | CN1073101C Substituted 1,2,3,4-tetrahydronaphthalene derivatives |
| 10/17/2001 | CN1072955C Tonic liquid of black ewe's placenta extract and its preparing method |
| 10/17/2001 | CN1072935C Prepn. method for medical compsns. contg. aza-steroid compound for treating prostatic hyperplasia |
| 10/17/2001 | CA2343843A1 Therapeutic light source and method |
| 10/16/2001 | US6303819 Sodium channel-blocking agent; chronic or neuropathic pain. |
| 10/16/2001 | US6303793 Intermediates for cyclin-dependent kinase inhibitors |
| 10/16/2001 | US6303789 Benzamides with tetrahydrofuranyloxy substitutents as phosphodiesterase 4 inhibitors |
| 10/16/2001 | US6303660 Enhanced anti-cancer agent delivery to solid tumors by primer compounds |
| 10/16/2001 | US6303653 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 10/16/2001 | US6303642 Use of 2-methyl-thiazolidine-2,4-dicarboxylic acid as a mucolytic agents |
| 10/16/2001 | US6303641 Cyanoamidines as cell proliferation inhibitors |
| 10/16/2001 | US6303640 Administering oxazole or thiazole derivative compound for reducing side effects of diabetic therapy |
| 10/16/2001 | US6303636 Arylsulfonylamino hydroxamic acid derivatives |
| 10/16/2001 | US6303634 Therapy and prophylaxis of breast cancer in a human by administering to human benzothiophene derivative |
| 10/16/2001 | US6303628 Bicycliccarbonyl indole compounds as anti-inflammatory/analgesic agents |
| 10/16/2001 | US6303627 For therapy of physiological and psychological disorders |
| 10/16/2001 | US6303626 Pharmaceutical formulations in dry form for the oral administration of a cyclic quaternary ammonium compound |
| 10/16/2001 | US6303618 Cyclin dependent kinase inhibiting purine derivatives |
| 10/16/2001 | US6303615 2,3 disubstituded-4(3H)-quinazolinones |
| 10/16/2001 | US6303613 As nitric oxide synthase inhibitor useful in therapy or prophylaxis of inflammatory disease and pain |
| 10/16/2001 | US6303611 For therapy of hyperalgesis |
| 10/16/2001 | US6303610 Method of treating gout with certain indole compounds |
| 10/16/2001 | US6303606 Use of selective antagonists of the α1B-adrenergic receptor for improvement of sexual dysfunction |
| 10/16/2001 | US6303605 For therapy of anxiety and convulsions |
| 10/16/2001 | US6303604 Pharmaceutical composition comprising 2,4-diamino-6-benzyloxy-s-triazine and inactivation of O6-alkylguanine-DNA-alkyltransferase |
| 10/16/2001 | US6303603 3-oxo-2(H)-1,2,4-triazine derivatives as ligands of 5 HT1A receptors |
| 10/16/2001 | US6303602 Useful as analgesic, anesthetic, anti-inflammatory or neuroprotective agent, or for therapy of arthritis, stroke of functional bowel disease |
| 10/16/2001 | US6303601 Arylgycinamide derivatives, methods of producing these substances and pharmaceutical compositions containing such compounds |
| 10/16/2001 | US6303600 Substituted azabicyclic compounds |
| 10/16/2001 | US6303597 For therapy of anxiety and convulsions |
| 10/16/2001 | US6303595 Use of mirtazapine for treating sleep apneas |
| 10/16/2001 | US6303572 Control of acidic gut syndrome |
| 10/16/2001 | US6303569 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents |
| 10/16/2001 | US6303374 By hybridization with nucleic acid; controlling apoptosis and programmed cell death; alzheimer*s, parkinson*s, autoimmune, and viral diseases; cancer; amyotrophic lateral sclerosis |
| 10/16/2001 | US6303347 Vaccines |
| 10/16/2001 | US6303342 Recombinant methods and materials for producing epothilones C and D |
| 10/16/2001 | US6303334 Nucleotide sequences coding polypeptides for use in as a viricide and in gene therapy |
| 10/16/2001 | US6303333 Expression vector which codes polypeptides for the diagnosis and treatment of cancer, dietetics, inflammation, cardiovascular disorders, crohn's diseases, neuropathies and immune defects |
| 10/16/2001 | US6303331 Vertebrate apoptosis gene: compositions and methods |
| 10/16/2001 | US6303321 Methods for diagnosing sepsis |
| 10/16/2001 | US6303319 Cell based assay for identifying sh2-domain-specific signal transducer antagonist |
| 10/16/2001 | US6303156 Noninvasive method for increasing or decreasing the body temperature of a patient |
| 10/16/2001 | US6303141 Passive sustained release transdermal drug delivery system |
| 10/16/2001 | US6303126 Treatment of fibrosis by HGF |
| 10/16/2001 | US6303121 Method of using human receptor protein 4-1BB |
| 10/16/2001 | US6303114 IL-12 enhancement of immune responses to T-independent antigens |
| 10/16/2001 | US6302837 Benzothiophene, benzofuran and indole compounds |
| 10/16/2001 | CA2096350C Treatment for osteoporosis using growth hormone release factor (grf) in combination with parathyroid hormone (pth) |
| 10/16/2001 | CA2089349C New pyrolidine derivatives, process for their preparation and pharmaceutical composition holding same |
| 10/16/2001 | CA2073351C Lysozyme dimers and method of preparing them |
| 10/16/2001 | CA2035967C Oxetanones |
| 10/16/2001 | CA2025301C New n-aryl and n-heteroarylamide and urea derivatives as inhibitors of acyl coenzyme a: cholesterol acyl transferase |
| 10/16/2001 | CA2015470C Fluorinated arachidonic acid derivatives |
| 10/14/2001 | CA2344183A1 Glycoprotein having inhibitory activity against helicobacter pylori colonization |
| 10/13/2001 | CA2343850A1 Synergistic effect of a sulfonylurea and/or non-sulfonylurea k+ atp channel blocker, and a phosphodiesterase 3 type inhibitor |
| 10/11/2001 | WO2001075164A2 Rna sequence-specific mediators of rna interference |
| 10/11/2001 | WO2001075135A1 Retinoic acid receptor beta-2, its antagonists, and gene therapy vectors for the treatment of neurological disorders |
| 10/11/2001 | WO2001075107A2 Use of p-selectin glycoprotein ligand-1 (psgl-1) and fragments thereof for the inhibition of thrombosis |
| 10/11/2001 | WO2001075084A2 Coffee mannanase |
| 10/11/2001 | WO2001075078A1 HUMAN AMINOACYL-tRNA SYNTHETASE POLYPEPTIDES USEFUL FOR THE REGULATION OF ANGIOGENESIS |
| 10/11/2001 | WO2001075074A1 Novel proteins |
| 10/11/2001 | WO2001075066A2 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 10/11/2001 | WO2001075064A2 Method and materials relating to insulin-like growth factor binding protein-like polypeptides and polynucleotides |
| 10/11/2001 | WO2001074900A2 Nuclear factor kb inducing factor |
| 10/11/2001 | WO2001074859A2 A gene differentially expressed in breast and bladder cancer and encoded polypeptides |
| 10/11/2001 | WO2001074856A2 Wnt-7b-like polypeptides and nucleic acids encoding same |
| 10/11/2001 | WO2001074844A2 Selective linear peptides with melanocortin-4 receptor (mc4-r) agonist activity |
| 10/11/2001 | WO2001074841A1 Human aminoacyl-trna synthetase polypeptides useful for the regulation of angiogenesis |
| 10/11/2001 | WO2001074837A1 Mammalian sphingosine kinase type 2 isoforms, cloning, expression and methods of use thereof |
| 10/11/2001 | WO2001074827A1 Phosphoramidate prodrugs |
| 10/11/2001 | WO2001074820A1 Novel derivatives and analogues of galanthamin |
| 10/11/2001 | WO2001074816A1 4-oxo-1,4-dihydro[1,8]naphthyridine-3-carboxamides as antiviral agents |